COVID-19 has been reported to trigger Guillain–Barré Syndrom
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain-Barré Syndrome in a 54-year-old man who had suffered from it twice and had a third occurrence after testing positive for COVID-19.

The team looked at about 1,200 hospital patients diagnosed with COVID-19 who were admitted and discharged between March and May of 2020 and this was the only instance where COVID-19 triggered the recurrence of Guillain-Barré Syndrome.

Guillain–Barré Syndrome can follow acute viral and bacterial infections, causing symptoms including weakness and tingling in the extremities. As the condition worsens, the weakness quickly spreads, eventually sometimes paralyzing the whole body. While most people recover from the condition, about 5% of people experience a recurrence.

We recommend that patients who develop COVID-19 and have a history of autoimmune [demyelinating] disorders should be closely observed for several weeks for neurologic symptoms, said Payal Parikh, assistant professor at Rutgers Robert Wood Johnson Medical School.

The findings will improve the understanding of the spectrum of Guillain-Barré Syndrome, which may be trigged by acute viral or bacterial infection, and help create treatments for COVID-19 patients.

Source:
https://www.mdpi.com/2076-0817/9/11/965
Dr. T●●●●z H●●●●●●i and 5 others like this3 shares
Like
Comment
Share